Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
90.00
Ask:
95.00
Spread: 5.00 (5.556%)
Market Cap: £6.08m
TIDE Live PriceLast checked at - London Stock Exchange

Intraday Crimson Tide Share Chart

Interim Results

28 Sep 2021 07:00

RNS Number : 1268N
Crimson Tide PLC
28 September 2021
Β 
28 September 2021Β Crimson Tide plcΒ Interim results for the six months ended 30 June 2021Β Crimson Tide plc ("Crimson Tide" or "the Company"), the provider of the mpro5 solution is pleased to announce its unaudited interim results for the six months ended 30 June 2021.Β 

Financial headlines

Β 

Β· Turnover increase of 13.8% to Β£2,015k (H1 2020: Β£1,770k)

Β· EBITDA increase of 12.5% to Β£529k (H1 2020: Β£470k)

Β· Profit before tax increased by 11.3% to Β£286k (H1 2020: Β£257)

Β· Fundraise of Β£5.6m (net of fees) finalised during April 2021, of which Β£250k spent in H1

Β 

Operational highlights

Β 

Β· Expansion of food safety use of mpro5

Β· Early progress on micro business version

Β· UAT completed for patient version of mpro5

Β· Raleigh, NC established as US base

Β· Significant hires in sales, marketing and development

Β 

Barrie Whipp, Founder and Chairman, commented,

Β 

"With the completed fundraise for expansion purposes, we are set to experience a new phase of growth as a business. We are now in a position to deliver our version of mpro5 for micro/nano business while mpro5 continues to perform strongly in our key enterprise sectors of transport, facilities management and retail. We are about to experience a period of significant expenditure on growth, which will change our profile in H2 2021 and 2022, with the firm belief that we have a bright future ahead".

Β 

About the Company

Crimson Tide plc is the provider of mpro5 - a leading, cloud-based, cross-platform, SaaS mobile workflow solution. mpro5 enables organisations to drive efficiencies through mobile data capture, Internet of Things sensors, process automation, and real-time analytics. Supporting over 100,000 users across multiple countries and industries, mpro5 is provided on multi-year subscription basis driving immediate return on investment for its users.

Β 

Enquiries:

Β 

Crimson Tide plc

Barrie Whipp / Luke Jeffrey

Β 

+44 1892 542444

finnCap Ltd (Nominated Adviser and Broker)

Corporate Finance: Julian Blunt / James Thompson

+44 20 7220 0500

Β 

Corporate Broking: Andrew Burdis

Β 

Alma PR (Financial PR)

Josh Royston

+44 7780 901979

Β 

Β 

Chairman's Statement

Β 

Β 

Β Β Β Β 
Β 

The first half of the year demonstrated the robustness of our long-term subscription model for mpro5, whilst setting us up for the largest capital raise in our history. With early wins in the food safety sector as well as the utility vertical, we were able to demonstrate the sound business model that attracted several highly respected investors in the AIM market to participate in our fundraising in April.

Β 

Our increased capital base and cash generated from mpro5's existing operations saw cash increase to in excess of Β£6.5m, and we are now in the early days of implementing the strategy presented to investors. We are addressing client feature requests for the core mpro5 platform which inherently enhances our sales process. Our enterprise deals, by their nature, can have longer lead times, however our abilities in IoT and dashboarding are making mpro5 even more compelling. We are currently focused on the transport, facilities management and retail sectors and our key model is to "land and expand" with enterprise clients. Part of this strategy is to be able to assist them wherever their business is located.

Β 

Internationally, we have established mpro5 Inc, based in Raleigh, North Carolina. This is not a grand physical strategy but a tactical approach, where our US CEO, Mark Self can approach existing clients (or clients of clients) as well as establish partnerships and relationships. Our mpro5 demo systems and marketing material can help us add new business based upon existing use cases. We have expanded into Scandinavia: whilst only in a very small way to date, this is an excellent example of how mpro5's value in the UK & Ireland is replicable with international clients in their other geographic markets. Adding the World Federation of Haemophilia to our subscription base also represents a highly exciting opportunity. Our patient app, previously applicable to patients with haemophilia has been completely reengineered to suit any condition where patients need to report usage of medication as well as verification that the medicine is in date, applicable to them and not counterfeit. We are as excited with the opportunities in this sector as any of our business verticals.

Β 

Project wrkrz, our version of mpro5 for micro/nano business is undergoing first stage development as well as market research, branding and technical stack progress on an ongoing basis. We aim for release in Q2, 2022 and it should be noted that many of the new learnings are also relevant to future developments in mpro5. Our market research indicates that there is a clear market for this low touch version of mpro5 in the trades sector and will see significant investment in the coming years.

Β 

This has been an important half year for Crimson Tide plc. With the capital backing that we have previously lacked, we can now invest in some of the opportunities that we know exist, as well as major partner acquisition, integration and more aggressive R&D. We feel that we can now market our business aggressively. I encourage you to visit mpro5.com to view our case studies and marketing material. This business has never been so well set. The addition of a Head of Marketing, US CEO and Jacqueline Daniell, as a new Non-Executive Director, has strengthened our executive and board significantly.

Β 

We are keenly focused on expanding the business in our key sectors, whilst exploring geographic opportunities and developing our micro business and patient versions of the mpro5 platform. We have strengthened our team, identified our marketing and development partners and will press ahead with ambition and optimism.

Β 

Β 

Β 

Barrie WhippFounder and Chairman28 September 2021

Β 

Β 

Β 

Financial Review

Β 

Financial indicator

Six months ended 30 June 2021Β£'000

Six months ended 30 June 2020Β£'000

Increase%

Year ended 31 December 2020Β£'000

Revenue

2,015

1,770

13.8%

3,542

Gross profit

1,652

1,404

17.7%

2,865

EBITDA

529

470

12.5%

946

Profit before tax

286

257

11.3%

532

Β 

The half-year financial results for 2021 reflect double-digit growth across all the key financial indicators.

Β 

Revenue

Revenue growth remained robust during the period, with monthly recurring revenue as at 30 June 2021 at cΒ£300,000 (H1 2020: cΒ£235,000). Consultancy fees contributed Β£178,000 to revenue during the period (H1 2020: Β£255,000). Revenue churn during the period remained low at 1.4% (H1 2020: 3.9%). Geographically the revenue split remained consistent to that of the prior year, with the UK contributing 92% of revenue (H1 2020: 93%).

Β 

Cost of Sales and gross profit

The gross profit margin of 82% remained above the Board's target rate of 80% (H1 2020: 79%).

Β 

Other income

Other income reflects the sale of legacy hardware devices. The nature of this is not recurring.

Β 

Cashflow

Operating cash flows before movement in working capital increased to Β£530,000 (H1 2020: Β£476,000). Although cash generated by operations of Β£111,000 (H1 2020: Β£1.03 million) appears to have decreased, this is mostly an effect of the measures that the Board put in place during the first lockdown in 2020 to preserve cash, with the subsequent correction taking place during the current period. Cash prior to the fundraise in April was cΒ£1m. Following the successful raise of Β£5.6 million (net of fees) at the end of April, the Company has spent approximately Β£250,000 on initiatives highlighted during the fundraise process. It is expected that this amount will increase during H2 2021. Investment in marketing will also increase, under the guidance of the newly appointed Head of Global Marketing.

Β 

Lease liabilities

Loans and leases decreased to Β£205,000 (H1 2020: Β£410,000) and obligations will conclude during the following 18 months. No new leases were entered into during the period under review.

Β 

Intangible asset

Software development costs of Β£259,000 (H1 2020: Β£229,000) were capitalised during the period under review, while amortisation amounted to Β£123,000 (H1 2020: Β£100,000). The value of the capitalised software intangible asset at period-end was Β£1.8 million (H1 2020: Β£1.45 million).

Β 

Earnings per share

Following the issue of 200 million ordinary shares on 23 April 2021, the total number of ordinary shares in issue at period end was 657,486,234 (H1 2020: 457,486,234). Basic and diluted earnings per share was 0.05p (H1 2020: 0.06p) during the period under review.

Β Β Crimson Tide plc

Condensed Consolidated Statement of Profit or Loss

for the 6 months to 30 June 2021

Β 

Β 

Unaudited

6 Months

ended

30 June

2021

Β 

Unaudited

6 Months

ended

30 June

2020

Β 

Audited

12 Months

ended 31

December

2020

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Revenue

2,015

Β 

1,770

Β 

3,542

Β 

Cost of Sales

(363)

Β 

(366)

Β 

(677)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Gross Profit

1,652

Β 

1,404

Β 

2,865

Β 

Other income

123

Β 

-

Β 

5

Β 

Administrative expenses

(1,477)

Β 

(1,128)

Β 

(2,309)

Β 

Operating profit

298

Β 

276

Β 

561

Β 

Finance costs

(12)

Β 

(19)

Β 

(29)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit before taxation

286

Β 

257

Β 

532

Β 

Taxation

-

Β 

-

Β 

202

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period attributable to equity holders of the parent

Β 

286

Β 

Β 

Β 

257

Β 

Β 

734

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Earnings per share

Unaudited

6 Months

ended

30 June

2021

Β 

Unaudited

6 Months

ended

30 June

2020

Β 

Audited

12 Months

ended 31

December

2020

Β 

Basic earnings per Ordinary Share

0.05p

Β 

0.06p

Β 

0.16p

Β 

Diluted earnings per Ordinary Share

0.05p

Β 

0.06p

Β 

0.16p

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Statement of Comprehensive Income

for the 6 months to 30 June 2021

Β 

Β 

Unaudited

6 Months

ended

30 June

2021

Β 

Unaudited

6 Months

ended

30 June

2020

Β 

Audited

12 Months

ended 31

December

2020

Β 

Β 

Β£000

Β 

Β£000

Β 

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

286

Β 

257

Β 

734

Β 

Β 

Other comprehensive income/(loss) for period:

Β 

Β 

Β 

Β 

Β 

Β 

Exchange differences on translating foreign operations

1

Β 

6

Β 

4

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive profit recognised in the period and attributable to equity holders of parent

Β 

287

Β 

Β 

263

Β 

Β 

738

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Statement of Financial Position at 30 June 2021

Β 

Β 

Unaudited

As at

30 June

2021

Β 

Unaudited

As at

30 June

2020

Β 

Audited

As at 31 December 2020

Β 

Β£000

Β 

Β£000

Β 

Β£000

ASSETS

Β 

Β 

Β 

Β 

Β 

Non-current assets

Β 

Β 

Β 

Β 

Β 

Intangible assets

2,577

Β 

2,247

Β 

2,441

Property, plant & equipment

189

Β 

291

Β 

235

Right-of-use asset

64

Β 

121

Β 

92

Deferred tax asset

32

Β 

32

Β 

32

Total non-current assets

2,862

Β 

2,691

Β 

2,800

Β 

Β 

Β 

Β 

Β 

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Inventories

6

Β 

6

Β 

6

Trade and other receivables

1,474

Β 

1,018

Β 

1,221

Cash and cash equivalents

6,596

Β 

1,052

Β 

1,175

Total current assets

8,076

Β 

2,076

Β 

2,402

Β 

Total assets

Β 

10,938

Β 

Β 

4,767

Β 

Β 

5,202

Β 

Β 

Β 

Β 

Β 

Β 

LIABILITIES

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Β 

Trade and other payables

741

Β 

820

Β 

907

Borrowings

7

Β 

18

Β 

8

Lease liabilities

134

Β 

221

Β 

181

Total current liabilities

882

Β 

1,059

Β 

1,096

Β 

Non-current liabilities

Β 

Β 

Β 

Β 

Β 

Borrowings

-

Β 

8

Β 

5

Lease liabilities

64

Β 

163

Β 

94

Total non-current liabilities

64

Β 

171

Β 

9

Β 

Β 

Β 

Β 

Β 

Β 

Total liabilities

946

Β 

1,230

Β 

1,195

Β 

Β 

Β 

Β 

Β 

Β 

Net assets

9,992

Β 

3,537

Β 

4,007

Β 

Β 

Β 

Β 

Β 

EQUITY

Β 

Β 

Β 

Β 

Β 

Share capital

657

Β 

457

Β 

457

Share premium

5,644

Β 

148

Β 

148

Other reserves

481

Β 

480

Β 

479

Reverse acquisition reserve

(5,244)

Β 

(5,244)

Β 

(5,244)

Retained profits

8,454

Β 

7,696

Β 

8,167

Β 

Β 

Β 

Β 

Β 

Β 

Total equity

9,992

Β 

3,537

Β 

4,007

Β 

Condensed Consolidated Statement of Changes in Equity

Β 

Six-month period ended 30 June 2021 (Unaudited)

Β 

Β 

Β 

Β 

Β 

Β 

Share capital

Β 

Β 

Share premium

Β 

Β 

Other reserves

Reverse acquisi-tion reserve

Β 

Β 

Retained earnings

Β 

Β 

Β 

Total

Β 

Β£000

Β£000

Β£000

Β£000

Β£000

Β£000

Balance at 31 December 2020

457

148

479

(5,244)

8,167

4,007

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Shares issued

200

5,496

-

-

-

5,696

Profit for the period

-

-

-

-

286

286

Translation movement

-

-

2

-

1

3

Balance at

30 June 2021

Β 

657

Β 

5,644

Β 

481

Β 

(5,244)

Β 

8,454

Β 

9,992

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Six-month period ended 30 June 2020 (Unaudited)

Β 

Β 

Β 

Share capital

Β 

Β 

Share premium

Β 

Β 

Other reserves

Reverse acquisi-tion reserve

Β 

Β 

Retained earnings

Β 

Β 

Β 

Total

Β 

Β£000

Β£000

Β£000

Β£000

Β£000

Β£000

Balance at 31 December 2019

457

148

475

(5,244)

7,433

3,269

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

-

257

257

Translation movement

-

-

5

-

6

11

Balance at

30 June 2020

Β 

457

Β 

148

Β 

480

Β 

(5,244)

Β 

7,696

Β 

3,537

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Statement of Changes in Equity

Β 

Year ended 31 December 2020 (Audited)

Β 

Β 

Β 

Share capital

Β 

Β 

Share premium

Β 

Β 

Other reserves

Reverse acquisi-tion reserve

Β 

Β 

Retained earnings

Β 

Β 

Β 

Total

Β 

Β£000

Β£000

Β£000

Β£000

Β£000

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 1 January 2020

457

148

475

(5,244)

7,433

3,269

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

-

734

734

Translation movement

-

-

4

-

-

4

Balance at

31 December 2020

Β 

457

Β 

148

Β 

479

Β 

(5,244)

Β 

8,167

Β 

4,007

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Condensed Consolidated Statement of Cash flows

For the 6 months to 30 June 2021

Β 

Β 

Unaudited

6 Months

ended

30 June

2021

Β 

Unaudited

6 Months

ended

30 June

2020

Β 

Audited

12 Months

ended

31 December

2020

Β 

Β£000

Β 

Β£000

Β 

Β£000

Cash flows from operating activities

Β 

Β 

Β 

Β 

Β 

Profit before tax

286

Β 

257

Β 

532

Adjustments for:

Β 

Β 

Β 

Β 

Β 

Amortisation of Intangible Assets

123

Β 

100

Β 

216

Depreciation of property, plant and equipment

80

Β 

66

Β 

111

Depreciation of right-of-use assets

28

Β 

28

Β 

57

Unrealised currency translation movement

1

Β 

6

Β 

4

Interest paid

12

Β 

19

Β 

29

Operating cash flows before movement in working capital and provisions

530

Β 

476

Β 

949

Decrease in inventories

-

Β 

6

Β 

6

(Increase)/decrease in trade and other receivables

(253)

Β 

202

Β 

(1)

(Decrease)/increase in trade and other payables

(166)

Β 

346

Β 

433

Cash generated by operations

111

Β 

1,030

Β 

1,387

Income taxes received

-

Β 

-

Β 

202

Interest paid in cash

(10)

Β 

(15)

Β 

(27)

Net cash from operating activities

101

Β 

1,015

Β 

1,562

Β 

Β 

Β 

Β 

Β 

Β 

Cash flows from investing activities

Β 

Β 

Β 

Β 

Β 

Purchases of property, plant and equipment

(34)

Β 

(32)

Β 

(21)

Development expenditure capitalised

(259)

Β 

(229)

Β 

(539)

Net cash used in investing activities

(293

)

(261)

Β 

(560)

Β 

Β 

Β 

Β 

Β 

Β 

Cash flows from financing activities

Β 

Β 

Β 

Β 

Β 

Net proceeds from share issues

5,696

Β 

-

Β 

-

Repayments of borrowings

(6)

Β 

(14)

Β 

(21)

Repayments of lease liability

(77)

Β 

(8)

Β 

(126)

Net cash from financing activities

5,613

Β 

(22)

Β 

(147)

Net increase in cash and cash equivalents

5,421

Β 

732

Β 

855

Β 

Β 

Β 

Β 

Β 

Β 

Net cash and cash equivalents at beginning of period

1,175

Β 

320

Β 

320

Net cash and cash equivalents at end of period

6,596

Β 

1,052

Β 

1,175

Β 

Crimson Tide Plc

Β 

Notes to the Unaudited Interim Results for the 6 months ended 30 June 2021

Β 

1. General information and basis of preparation

Β 

Crimson Tide plc is a public company, limited by shares, and incorporated and domiciled in the United Kingdom. The Company has its listing on AIM. The address of its registered office is Oakhurst House, 77 Mt. Ephraim, Tunbridge Wells, Kent, TN4 8BS.

Β 

Basis of preparation

The condensed consolidated interim financial statements ("interim financial statements") have been prepared in accordance with International Accounting Standard 34 Interim Financial Reporting using accounting policies that are consistent with those applied in the previously published financial statements for the year ended 31 December 2020, which have been prepared in accordance with IFRS as adopted by the European Union.

Β 

The information for the period ended 30 June 2021 has neither been audited nor reviewed and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.

Β 

The interim financial statements should be read in conjunction with the consolidated financial statements for the year ended 31 December 2020. A copy of the statutory accounts for that period has been delivered to the Registrar of Companies. The auditor's report on those accounts was unqualified and did not contain statements under section 498 (2) or (3) of the Companies Act 2006.

Β 

Going concern

The financial statements are prepared on the going concern basis. The financial position of the Company, its cash flows and liquidity position are described in the interim financial statement and notes. The Company has the financial resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report.

Β 

2. Revenue and operating segments

Β 

The Group has two main regional centres of operation; one in the UK, the other in Ireland but the Group's resources, including capital, human and non-current assets are utilised across the Group irrespective of where they are based or originate from. The Board is the chief operating decision maker ("CODM"). The CODM allocates these resources based on revenue generation, which due to its high margin nature and the Group's reasonably fixed overheads, in turn drives profitability and cashflow generation. The Board consider it most meaningful to monitor financial results and KPIs for the consolidated Group, and decisions are made by the Board accordingly.

Β 

In due consideration of the requirements of IFRS 8 Operating Segments, the Board consider segmental reporting by (i) business activity, by turnover, and (ii) region, by turnover to be appropriate. Business activity is best split between (i) the strategic focus of the business, i.e. mobility solutions and the resulting development services that emanate from that, (ii) non-core software solutions, including reselling third party software and related development and support services, and (iii) hardware sales to existing customers.

Β 

Segment information for the reporting periods is as follows:

Β 

Β 

Β 

Β 

Β 

Β Unaudited

Β 6 Months

ended

30 June

2021

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2020

Β 

Β 

Audited

Β 12 Months

ended 31

December

2020

Β 

Revenue by business activity

Β 

Β 

Β 

Mobility solutions and related development

1,837

1,290

3,212

Software consultancy

178

255

330

Hardware sales

-

225

-

Β 

2,015

1,770

3,542

Β 

Β 

Revenue can be further analysed by geographic reason as follows:

Β 

Β 

Β 

Β Unaudited

Β 6 Months

ended

30 June

2021

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2020

Β 

Β 

Audited

Β 12 Months

ended 31

December

2020

Β 

Revenue by geographic region

Β 

Β 

Β 

UK

1,855

1,640

3,233

European Union

140

118

275

Rest of the world

20

12

34

Β 

2,015

1,770

3,542

Β 

Β 

3. Earnings per share

Β 

The calculation of the basic earnings per share is based on the profit attributable to ordinary shareholders and the weighted average number of ordinary shares in issue during the period.

Β 

The calculation of the diluted earnings per share is based on the profit per share attributable to ordinary shareholders and the weighted average number of ordinary shares that would be in issue, assuming conversion of all dilutive potential ordinary shares into ordinary shares.

Β 

Reconciliations of the profit and weighted average number of ordinary shares used in the calculation are set out below:

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Unaudited

Β 6 Months

ended

30 June

2021

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2020

Β 

Β 

Audited

Β 12 Months

ended 31

December

2020

Β 

Earnings per share

Β 

Β 

Β 

Reported profit (Β£000)

286

257

734

Reported basic earnings per share (pence)

0.05

0.06

0.16

Reported diluted earnings per share (pence)

0.05

0.06

0.16

Β 

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2021

Β 

Β 

Unaudited

Β 6 Months

ended

30 June

2020

Β 

Β 

Audited

Β 12 Months

ended 31

December

2020

Β 

Β 

No. 000

No. 000

No. 000

Weighted average number of ordinary shares

Β 

Β 

Β 

Shares in issue at start of period

457,486

457,486

457,486

Effect of shares issued during the period*

76,243

-

-

Weighted average number of ordinary

shares for basic EPS

Β 

533,729

Β 

457,486

Β 

457,486

Effect of share options outstanding

291

-

2,939

Weighted average number of ordinary

shares for diluted EPS

Β 

534,020

Β 

457,486

Β 

460,425

Β 

Β 

Β 

Β 

Β 

*200 million ordinary shares were issued on 23 April 2021.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR UBUNRAWUKUAR
Date   Source Headline
9th Jun 20267:00 amRNS-RNew contract trials: Sim Trava and DW Baking
5th Jun 202612:26 pmRNSHolding(s) in Company
5th May 20267:00 amRNSYear End Trading Update
24th Apr 20267:00 amRNSAIM Director Disclosure Update
2nd Apr 20267:00 amRNS-RNew Contract Wins
9th Mar 202610:00 amRNSConcert Party Update
26th Feb 20267:00 amRNSNon-Executive Director Appointments
18th Feb 20267:00 amRNS-RRenewal of Contract
23rd Jan 20267:00 amRNSChange of Non-Executive Director
29th Dec 20259:21 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSCustomer Contracts Update
4th Dec 20255:43 pmRNSHolding(s) in Company
27th Nov 20257:00 amRNSDirector/PDMR Shareholding - Grant of Options
19th Nov 20257:00 amRNSInterim Results
10th Nov 20253:14 pmRNSContract Renewal with Major Global Retailer
3rd Nov 20254:20 pmRNSHolding(s) in Company
31st Oct 20252:46 pmRNSResult of AGM
31st Oct 20259:28 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSAGM Statement
27th Oct 20254:45 pmRNSHolding(s) in Company
27th Oct 20254:43 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSAudited Full Year Results
29th Sep 20257:00 amRNSUpdate on Audited Results
22nd Jul 20257:00 amRNSAppointment of Chief Executive Officer
14th Jul 20252:40 pmRNSHolding(s) in Company
7th Jul 20257:00 amRNSContract Renewal with Major UK Wholesaler
4th Jul 20257:00 amRNSAppointment of Finance Director
12th Jun 202510:46 amRNSHolding(s) in Company
5th Jun 20257:00 amRNSAppointment of Chair, Nominated Adviser and Broker
30th May 20257:00 amRNSSecond Interim Results
29th May 20257:00 amRNSContract Renewal with Major British Supermarket
6th May 20257:00 amRNSChange of Accounting Reference Date
15th Apr 20253:58 pmRNSBoard Appointment
26th Mar 202511:00 amRNSBoard Changes
20th Mar 20252:29 pmRNSBoard Change
20th Mar 202512:36 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:25 amRNSForm 8.5 (EPT/RI)
19th Mar 202511:50 amRNSResults of Court Meeting and General Meeting
18th Mar 20259:35 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 20253:06 pmGNWForm 8.3 - Crimson Tide Plc
17th Mar 202512:00 pmRNSForm 8.5 (EPT/RI)
14th Mar 20253:05 pmGNWForm 8.3 - Crimson Tide Plc
14th Mar 202511:58 amRNSForm 8.5 (EPT/RI)
12th Mar 202512:05 pmRNSForm 8.5 (EPT/RI)
12th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 202510:32 amRNSForm 8.5 (EPT/RI)
11th Mar 20257:00 amRNSOffer Update
10th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
7th Mar 202512:23 pmRNSForm 8.3 - Crimson Tide plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.